首页 正文

Anti-cancer drugs. 2022 Jan 1;33(1):80-90. doi: 10.1097/CAD.0000000000001133 Q32.22025

Comorbidities and mortality risk among extensive-stage small-cell lung cancer patients in mainland China: impacts of hypertension, type 2 diabetes mellitus, and chronic hepatitis B virus infection

中国大陆广泛期小细胞肺癌患者的并发症与死亡风险:高血压、2型糖尿病和慢性乙型肝炎病毒感染的影响 翻译改进

Weigang Xiu  1, Yin Huang, Yanying Li, Min Yu, Youling Gong

作者单位 +展开

作者单位

  • 1 Department of Thoracic Oncology and State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, PR China.
  • DOI: 10.1097/CAD.0000000000001133 PMID: 34183497

    摘要 Ai翻译

    The present study investigated the impact of major comorbidities, including hypertension, type 2 diabetes mellitus (T2DM), and chronic hepatitis B virus (HBV) infection, on the progression-free survival (PFS) and overall survival (OS) of extensive-stage small-cell lung cancer (ES-SCLC) patients in China. Patients having a pathologic diagnosis of ES-SCLC between 2009 and 2017 were enrolled and grouped according to their specific comorbidities. The PFS and O... ...点击完成人机验证后继续浏览
    Copyright © Anti-cancer drugs. 中文内容为AI机器翻译,仅供参考!

    相关内容

    期刊名:Anti-cancer drugs

    缩写:ANTI-CANCER DRUG

    ISSN:0959-4973

    e-ISSN:1473-5741

    IF/分区:2.2/Q3

    文章目录 更多期刊信息

    全文链接
    引文链接
    复制
    已复制!
    推荐内容
    Comorbidities and mortality risk among extensive-stage small-cell lung cancer patients in mainland China: impacts of hypertension, type 2 diabetes mellitus, and chronic hepatitis B virus infection